Spoken Alpha
HCA Healthcare, Inc.
HCA Healthcare operates 190 hospitals, 121 ambulatory surgery centers, and 31 endoscopy centers across 19 states and England, providing inpatient and outpatient medical services including emergency care, surgery, intensive care, behavioral health, and rehabilitation services to patients covered by Medicare, Medicaid, managed care plans, and private insurance.
HCA Healthcare, Inc is a Healthcare company operating in Medical Care Facilities with a $92.79B market cap.
Most recent reported earnings: Q3 FY2026 (Oct 22, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HCA.
$ curl https://api.spokenalpha.com/v1/companies/HCAFAQ
Spoken Alpha indexes HCA's earnings call transcripts at https://spokenalpha.com/companies/HCA. Each call links to attributed speakers and parsed analyst Q&A. HCA Healthcare, Inc.'s own investor relations page is at https://investor.hcahealthcare.com/overview/default.aspx.
HCA Healthcare, Inc. (HCA) held its most recent earnings call on 2026-07-24, covering fiscal Q2 2026.
HCA Healthcare, Inc. (HCA) operates in the Healthcare sector (Medical Care Facilities industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-22 | — | $6.80 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-23 | $7.59 | $7.57 | +0.3% | $20.23B | — | — | EODHD |
| Q1 FY2026 | 2026-04-23 | $7.15 | $7.13 | +0.3% | $19.11B | — | — | EODHD |
| Q4 FY2025 | 2026-01-26 | $8.01 | $7.48 | +7.1% | $19.51B | — | — | EODHD |
| Q3 FY2025 | 2025-10-23 | $6.96 | $5.73 | +21.5% | $19.16B | — | — | EODHD |
| Q2 FY2025 | 2025-07-24 | $6.84 | $6.32 | +8.2% | $18.61B | — | — | EODHD |
| Q1 FY2025 | 2025-04-24 | $6.45 | $5.75 | +12.2% | $18.32B | — | — | EODHD |
| Q4 FY2024 | 2025-01-23 | $6.22 | $6.14 | +1.3% | $18.29B | — | — | EODHD |
| Q3 FY2024 | 2024-10-24 | $4.90 | $4.98 | -1.6% | $17.49B | — | — | EODHD |
| Q2 FY2024 | 2024-07-22 | $5.50 | $4.93 | +11.6% | $17.49B | — | — | EODHD |
| Q1 FY2024 | 2024-04-25 | $5.36 | $5.09 | +5.3% | $17.34B | — | — | EODHD |
| Q4 FY2023 | 2024-01-29 | $5.90 | $5.05 | +16.8% | $17.30B | — | — | EODHD |
| Q3 FY2023 | 2023-10-23 | $3.91 | $3.97 | -1.5% | $16.21B | — | — | EODHD |
| Q2 FY2023 | 2023-07-26 | $4.29 | $4.24 | +1.2% | $15.86B | — | — | EODHD |
| Q1 FY2023 | 2023-04-20 | $4.93 | $3.92 | +25.8% | $15.59B | — | — | EODHD |
| Q4 FY2022 | 2023-01-26 | $4.64 | $4.79 | -3.1% | $15.50B | — | — | EODHD |
| Q3 FY2022 | 2022-10-20 | $3.93 | $3.86 | +1.8% | $14.97B | — | — | EODHD |
| Q2 FY2022 | 2022-07-21 | $4.21 | $3.71 | +13.5% | $14.82B | — | — | EODHD |
| Q1 FY2022 | 2022-04-21 | $4.12 | $4.24 | -2.8% | $14.95B | — | — | EODHD |
| Q4 FY2021 | 2022-01-26 | $4.42 | $4.52 | -2.2% | $15.06B | — | — | EODHD |
Source: EODHD. HCA reported actuals as published; sparse fields render as —.